Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole

Chemistry and Biology

Volumn 12, Issue 11, 2005, Pages 1211-1219

  Battistutta, Roberto ^a,b   Mazzorana, Marco ^a,b   Sarno, Stefania ^a,b   Kazimierczuk, Zygmunt ^c   Zanotti, Giuseppe ^a,b   Pinna, Lorenzo A ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4,5,6,7 TETRABROMOBENZIMIDAZOLE; 4,5,6,7-TETRABROMOBENZIMIDAZOLE; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; BROMINE; CASEIN KINASE II; PROTEIN KINASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; HYDROPHOBICITY; IC 50; METABOLISM; MUTATION; PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

BENZIMIDAZOLES; BROMINE; CASEIN KINASE II; HUMANS; HYDROPHOBICITY; INHIBITORY CONCENTRATION 50; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTATION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27744504303     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2005.08.015     Document Type: Article

References (55)

1. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
2. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
3. P. Cohen Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1 2002 309 315
4. C.L. Sawyers Rational therapeutic intervention in cancer: kinases as drug targets Curr. Opin. Genet. Dev. 12 2002 111 115
5. D. Fabbro, D. Parkinson, and A. Matter Protein tyrosine kinase inhibitors: new treatment modalities? Curr. Opin. Pharmacol. 2 2002 374 381
6. L.A. Pinna P.T.W. Cohen Inhibitors of Protein Kinases and Protein Phosphatases. Handbook of Experimental Pharmacology 167 2005 Springer-Verlag Berlin Heidelberg
7. M.E. Noble, J.A. Endicott, and L.N. Johnson Protein kinase inhibitors: insights into drug design from structure Science 303 2004 1800 1805
8. P. Traxler, and P. Furet Strategies toward the design of novel and selective protein tyrosine kinase inhibitors Pharmacol. Ther. 82 1999 195 206
9. T. Schindler, W. Bornmann, P. Pellicena, W.T. Miller, B. Clarkson, and J. Kuriyan Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase Science 289 2000 1938 1942
10. M. Gassel, C. Breitenlechner, S. Herrero, R. Engh, and D. Bossemeyer Inhibitors of PKA and Related Protein Kinases L.A. Pinna P.T.W. Cohen Inhibitors of protein kinases and protein phosphatases. Handbook of Experimental Pharmacology 167 2005 Springer-Verlag Berlin Heidelberg 85 124
11. R. Battistutta, S. Sarno, and G. Zanotti Inhibitors of Protein Kinase CK2: Structural Aspects L.A. Pinna P.T.W. Cohen Inhibitors of protein kinases and protein phosphatases. Handbook of Experimental Pharmacology 167 2005 Springer-Verlag Berlin Heidelberg 125 155
12. F. Meggio, and L.A. Pinna One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17 2003 349 368
13. L.A. Pinna The raison d'etre of constitutively active protein kinases: the lesson of CK2 Acc. Chem. Res. 36 2003 378 384
14. L.A. Pinna Protein kinase CK2: a challenge to canons J. Cell Sci. 115 2002 3873 3878
15. D.W. Litchfield Protein kinase CK2: structure, regulation and role in cellular decisions of life and death Biochem. J. 369 2003 1 15
16. K. Niefind, B. Guerra, I. Ermakowa, and O.G. Issinger Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme EMBO J. 20 2001 5320 5331
17. S. Tawfic, S. Yu, H. Wang, R. Faust, A. Davis, and K. Ahmed Protein kinase CK2 signal in neoplasia Histol. Histopathol. 16 2001 573 582
18. D.C. Seldin, and P. Leder Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle Science 267 1995 894 897
19. M.A. Kelliher, D.C. Seldin, and P. Leder Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha EMBO J. 15 1996 5160 5166
20. M. Orlandini, F. Semplici, R. Ferruzzi, F. Meggio, L.A. Pinna, and S. Oliviero Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation J. Biol. Chem. 273 1998 21291 21297
21. E. Landesman-Bollag, P.L. Channavajhala, R.D. Cardiff, and D.C. Seldin p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice Oncogene 16 1998 2965 2974
22. G. Wang, K.A. Ahmad, and K. Ahmed Modulation of death receptor-mediated apoptosis by CK2 Mol. Cell. Biochem. 274 2005 201 205
23. J.W. Critchfield, J.E. Coligan, T.M. Folks, and S.T. Butera Casein kinase II is a selective target of HIV-1 transcriptional inhibitors Proc. Natl. Acad. Sci. USA 94 1997 6110 6115
24. S. Sarno, E. de Moliner, M. Ruzzene, M.A. Pagano, R. Battistutta, J. Bain, D. Fabbro, J. Schoepfer, M. Elliott, and P. Furet Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA) Biochem. J. 374 2003 639 646
25. H. Yim, Y.H. Lee, C.H. Lee, and S.K. Lee Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor Planta Med. 65 1999 9 13
26. F. Meggio, M.A. Pagano, S. Moro, G. Zagotto, M. Ruzzene, S. Sarno, G. Cozza, J. Bain, M. Elliott, and A.D. Deana Inhibition of protein kinase CK2 by condensed polyphenolic derivatives: an in vitro and in vivo study Biochemistry 43 2004 12931 12936
27. E. Vangrevelinghe, K. Zimmermann, J. Schoepfer, R. Portmann, D. Fabbro, and P. Furet Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking J. Med. Chem. 46 2003 2656 2662
28. Z. Kazimierczuk, R. Stolarski, and D. Shugar Stereospecific synthesis by the sodium salt glycosylation method of halogeno benzimidazole 2′-deoxyribose analogues of the inhibitor of hnRNA synthesis, 5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole (DRB) Z. Naturforsch. [C] 40 1985 715 720
29. R. Zandomeni, M.C. Zandomeni, D. Shugar, and R. Weinmann Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D- ribofuranosylbenzimidazole of specific RNA polymerase II transcription J. Biol. Chem. 261 1986 3414 3419
30. S. Sarno, H. Reddy, F. Meggio, M. Ruzzene, S.P. Davies, A. Donella Deana, D. Shugar, and L.A. Pinna Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2') FEBS Lett. 496 2001 44 48
31. M. Ruzzene, D. Penzo, and L.A. Pinna Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells Biochem. J. 364 2002 41 47
32. J.I. Loizou, S.F. El-Khamisy, A. Zlatanou, D.J. Moore, D.W. Chan, J. Qin, S. Sarno, F. Meggio, L.A. Pinna, and K.W. Caldecott The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks Cell 117 2004 17 28
33. Y. Miyata, and E. Nishida CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37 Mol. Cell. Biol. 24 2004 4065 4074
34. G. Di Maira, M. Salvi, G. Arrigoni, O. Marin, S. Sarno, F. Brustolon, L.A. Pinna, and M. Ruzzene Protein kinase CK2 phosphorylates and upregulates Akt/PKB Cell Death Differ. 12 2005 668 677
35. S. Sarno, M. Ruzzene, P. Frascella, M.A. Pagano, F. Meggio, A. Zambon, M. Mazzorana, G. Di Maira, V. Lucchini, and L.A. Pinna Development and exploitation of CK2 inhibitors Mol. Cell. Biochem. 274 2005 69 76
36. M.A. Pagano, M. Andrzejewska, M. Ruzzene, S. Sarno, L. Cesaro, J. Bain, M. Elliott, F. Meggio, Z. Kazimierczuk, and L.A. Pinna Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole J. Med. Chem. 47 2004 6239 6247
37. R. Battistutta, E. De Moliner, S. Sarno, G. Zanotti, and L.A. Pinna Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole Protein Sci. 10 2001 2200 2206
38. L.M. Toledo, N.B. Lydon, and D. Elbaum The structure-based design of ATP-site directed protein kinase inhibitors Curr. Med. Chem. 6 1999 775 805
39. G. Scapin Structural biology in drug design: selective protein kinase inhibitors Drug Discov. Today 7 2002 601 611
40. M.A. Pagano, F. Meggio, M. Ruzzene, M. Andrzejewska, Z. Kazimierczuk, and L.A. Pinna 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2 Biochem. Biophys. Res. Commun. 321 2004 1040 1044
41. M. Andrzejewska, M.A. Pagano, F. Meggio, A.M. Brunati, and Z. Kazimierczuk Polyhalogenobenzimidazoles: synthesis and their inhibitory activity against casein kinases Bioorg. Med. Chem. 11 2003 3997 4002
42. R. Battistutta, S. Sarno, E. De Moliner, E. Papinutto, G. Zanotti, and L.A. Pinna The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 J. Biol. Chem. 275 2000 29618 29622
43. E. De Moliner, S. Moro, S. Sarno, G. Zagotto, G. Zanotti, L.A. Pinna, and R. Battistutta Inhibition of protein kinase CK2 by anthraquinone-related compounds: a structural insight J. Biol. Chem. 278 2003 1831 1836
44. K. Niefind, M. Putter, B. Guerra, O.G. Issinger, and D. Schomburg GTP plus water mimic ATP in the active site of protein kinase CK2 Nat. Struct. Biol. 6 1999 1100 1103
45. E. De Moliner, N.R. Brown, and L.N. Johnson Alternative binding modes of an inhibitor to two different kinases Eur. J. Biochem. 270 2003 3174 3181
46. J.P.M. Lommerse, A.J. Stone, R. Taylor, and F.H. Allen The nature and geometry of intermolecular interactions between halogens and oxygen or nitrogen J. Am. Chem. Soc. 118 1996 3108 3116
47. P. Auffinger, F.A. Hays, E. Westhof, and P.S. Ho Halogen bonds in biological molecules Proc. Natl. Acad. Sci. USA 101 2004 16789 16794
48. S. Sarno, P. Vaglio, F. Meggio, O.G. Issinger, and L.A. Pinna Protein kinase CK2 mutants defective in substrate recognition: purification and kinetic analysis J. Biol. Chem. 271 1996 10595 10601
49. A.G.W. Leslie Molecular data processing D. Moras A.D. Podjarny J.P. Thierry Crystallographic Computing V 1991 Oxford University Press Oxford 50 61
50. CCP4 The CCP4 suite: programs for protein crystallography Acta Crystallogr. D50 1994 760 763
51. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, and N.S. Pannu Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54 1998 905 921
52. G.M. Sheldrick, and T.R. Schneider SHELXL: high-resolution refinement Methods Enzymol. 277 1997 319 343
53. G.J. Kleywegt, and T.A. Jones Databases in protein crystallography Acta Crystallogr. D 54 1998 1119 1131
54. Accelrys (1998). QUANTA Version 98.1111 (computer program). Accelrys, San Diego, California.
55. R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structure J. Appl. Crystallogr. 26 1993 283 291